azopt ophthalmic suspension 1%
novartis (singapore) pte ltd - brinzolamide - solution - 10 mg/ml - brinzolamide 10 mg/ml
azopt 1%
novartis israel ltd - brinzolamide - ophthalmic suspension - brinzolamide 1 % - brinzolamide - brinzolamide - alcon azopt is indicated to decrease elevated intraocular pressure in: ocular hypertension open-angle glaucoma as monotherapy in patients unresponsive to beta-blockers or in patients in whom beta-blockers are contra-indicated or as adjunctive therapy to beta-blockers.
brinzolamide 10mg/ml eye drops suspension
wockhardt uk ltd - brinzolamide - eye drops, suspension - 10mg/ml - antiglaucoma preparations and miotics, carbonic anhydrase inhibitors - it is indicated to decrease elevated intraocular pressure in: • ocular hypertension • open-angle glaucoma as monotherapy in adult patients unresponsive to beta-blockers or in adult patients in whom beta-blockers are contraindicated, or as adjunctive therapy to beta-blockers or prostaglandin analogues
brinzolamide 10mg/ml eye drops, suspension
teva uk limited, eastbourne - brinzolamide - eye drops, suspension - 10mg/ml - antiglaucoma preparations and miotics, carbonic anhydrase inhibitors - it is indicated to decrease elevated intraocular pressure in: • ocular hypertension • open-angle glaucoma as monotherapy in adult patients unresponsive to beta-blockers or in adult patients in whom beta-blockers are contraindicated, or as adjunctive therapy to beta-blockers or prostaglandin analogues
brinzolamide 10mg/ml eye drops, suspension
generics [uk] limited t/a mylan - brinzolamide - eye drops, suspension - 10mg/ml - antiglaucoma preparations and miotics, carbonic anhydrase inhibitors - it is indicated to decrease elevated intraocular pressure in: • ocular hypertension • open-angle glaucoma as monotherapy in adult patients unresponsive to beta-blockers or in adult patients in whom beta-blockers are contraindicated, or as adjunctive therapy to beta-blockers or prostaglandin analogues
brinzolamide 10mg/ml eye drops, suspension
pharmathen s.a - brinzolamide - eye drops, suspension - 10mg/ml - antiglaucoma preparations and miotics, carbonic anhydrase inhibitors - it is indicated to decrease elevated intraocular pressure in: • ocular hypertension • open-angle glaucoma as monotherapy in adult patients unresponsive to beta-blockers or in adult patients in whom beta-blockers are contraindicated, or as adjunctive therapy to beta-blockers or prostaglandin analogues
brinzolamide
actavis group ptc ehf - brinzolamide - eye drops suspension - 10 mg/ml - brinzolamide - antiglaucoma preparations and miotics, carbonic anhydrase inhibitors - brinzolamide actavis is indicated to decrease elevated intraocular pressure in: • ocular hypertension • open-angle glaucoma as monotherapy in adult patients unresponsive to beta-blockers or in adult patients in whom beta-blockers are contraindicated, or as adjunctive therapy to beta-blockers or prostaglandin analogues
azopt
novartis europharm limited - brinzolamide - glaucoma, open-angle; ocular hypertension - ophthalmologicals - azopt is indicated to decrease elevated intraocular pressure in:ocular hypertension;open-angle glaucomaas monotherapy in adult patients unresponsive to beta-blockers or in adult patients in whom beta-blockers are contraindicated, or as adjunctive therapy to beta-blockers or prostaglandin analogues.
azopt suspension
novartis pharmaceuticals canada inc - brinzolamide - suspension - 1% - brinzolamide 1% - carbonic anhydrase inhibitors
azopt 10mgml eye drops
novartis pharmaceuticals uk ltd - brinzolamide - eye drops - 10mg/1ml